{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:47Z","timestamp":1793237687079,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacadv.2026.103058","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:00:25Z","timestamp":1784754025000},"page":"103058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mortality in Patients With Hodgkin Lymphoma and Heart Failure"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-9285","authenticated-orcid":false,"given":"Sissel Johanne","family":"Godtfredsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Eloranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin E.","family":"Smedby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Antonilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Baech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Kragholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarec C.","family":"El-Galaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8231-8183","authenticated-orcid":false,"given":"Caroline E.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacadv.2026.103058_bib1","first-page":"264","article-title":"Prognostic impact over time of ischaemic heart disease vs. non-ischaemic heart disease in heart failure","volume":"7","author":"Silverdal","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.jacadv.2026.103058_bib2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103058_bib3","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103058_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.15603","article-title":"Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines","volume":"183","author":"Baech","year":"2018","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103058_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A clinicopathologic analysis of adriamycin cardiotoxicity","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jacadv.2026.103058_bib6","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jha2.1048","article-title":"Congestive heart failure after anthracycline-containing treatment for Hodgkin lymphoma: a Swedish matched cohort study","volume":"5","author":"Baech","year":"2024","journal-title":"EJHaem"},{"key":"10.1016\/j.jacadv.2026.103058_bib7","article-title":"Risk of cardiovascular disease in patients with classical hodgkin lymphoma: a Danish nationwide register-based cohort study","author":"Godtfredsen","year":"2024","journal-title":"Eur J Haematol"},{"issue":"10450","key":"10.1016\/j.jacadv.2026.103058_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(24)01315-1","article-title":"Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial","volume":"404","author":"Borchmann","year":"2024","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.jacadv.2026.103058_bib9","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa2405888","article-title":"Nivolumab+AVD in advanced-stage classic Hodgkin\u2019s lymphoma","volume":"391","author":"Herrera","year":"2024","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jacadv.2026.103058_bib10","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1002\/cam4.1572","article-title":"Long-term risk of cardiovascular mortality in lymphoma survivors: a systematic review and meta-analysis","volume":"7","author":"Boyne","year":"2018","journal-title":"Cancer Med"},{"issue":"18","key":"10.1016\/j.jacadv.2026.103058_bib11","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/cncr.34375","article-title":"Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors","volume":"128","author":"Lu","year":"2022","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.jacadv.2026.103058_bib12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.116.022514","article-title":"Cardiac mortality among 200 000 five-year survivors of cancer diagnosed at 15 to 39 years of age","volume":"134","author":"Henson","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103058_bib13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bjh.19272","article-title":"Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: a Danish population-based study","volume":"204","author":"Baech","year":"2024","journal-title":"Br J Haematol"},{"issue":"15","key":"10.1016\/j.jacadv.2026.103058_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N Engl J Med"},{"issue":"49","key":"10.1016\/j.jacadv.2026.103058_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jncimonographs\/lgu024","article-title":"Cancer survival: an overview of measures, uses, and interpretation","volume":"2014","author":"Mariotto","year":"2014","journal-title":"JNCI Monographs"},{"key":"10.1016\/j.jacadv.2026.103058_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2340\/1651-226X.2024.40431","article-title":"The National Swedish Lymphoma register - a systematic validation of data quality","volume":"63","author":"Ekstr\u00f6m Smedby","year":"2024","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103058_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacadv.2026.103058_bib18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/CLEP.S164456","article-title":"Sampling strategies for selecting general population comparison cohorts","volume":"10","author":"Heide-J\u00f8rgensen","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.jacadv.2026.103058_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103058_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bcpt.12613","article-title":"The first decade with the Swedish prescribed drug register - a systematic review of the output in the scientific literature","volume":"119","author":"Wallerstedt","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.jacadv.2026.103058_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103058_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"issue":"11","key":"10.1016\/j.jacadv.2026.103058_bib23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jclinepi.2009.01.010","article-title":"Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995","volume":"62","author":"Johansson","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.jacadv.2026.103058_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/1403494813499653","article-title":"Accuracy of death certificates of cardiovascular disease in a community intervention in Sweden","volume":"41","author":"Eriksson","year":"2013","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.jacadv.2026.103058_bib25","doi-asserted-by":"crossref","DOI":"10.2196\/57840","article-title":"Population-level distribution, risk factors, and burden of mortality and disability-adjusted life years attributable to major noncommunicable diseases in Western Europe (1990-2021): ecological analysis","volume":"10","author":"Mubarik","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.jacadv.2026.103058_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102230","article-title":"Ranking age-specific modifiable risk factors for cardiovascular disease and mortality: evidence from a population-based longitudinal study","volume":"64","author":"Tian","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"19","key":"10.1016\/j.jacadv.2026.103058_bib27","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/jama.2023.5942","article-title":"Global variations in heart failure etiology, management, and outcomes","volume":"329","author":"Rasmussen","year":"2023","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.jacadv.2026.103058_bib28","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1200\/JCO.2017.76.3920","article-title":"Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention","volume":"36","author":"Armenian","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103058_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/clc.23754","article-title":"Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: a systemic review and meta-analysis","volume":"45","author":"Liang","year":"2022","journal-title":"Clin Cardiol"},{"issue":"22","key":"10.1016\/j.jacadv.2026.103058_bib30","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacadv.2026.103058_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/JCO.18.01652","article-title":"Relapse risk and loss of lifetime after modern combined modality treatment of young patients with Hodgkin lymphoma: a Nordic lymphoma epidemiology group study","volume":"37","author":"Biccler","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103058_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","article-title":"Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease","volume":"25","author":"Heidenreich","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103058_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-8140(99)00026-2","article-title":"Ischemic heart disease after mantlefield irradiation for Hodgkin\u2019s disease in long-term follow-up","volume":"51","author":"Reinders","year":"1999","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103058_bib34","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ahj.2004.12.026","article-title":"Diastolic dysfunction after mediastinal irradiation","volume":"150","author":"Heidenreich","year":"2005","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.jacadv.2026.103058_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","article-title":"Asymptomatic cardiac disease following mediastinal irradiation","volume":"42","author":"Heidenreich","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103058_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacadv.2026.103058_bib37","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1200\/JCO.2012.45.2714","article-title":"Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006)","volume":"31","author":"Eloranta","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103058_bib38","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/ijc.32142","article-title":"Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients","volume":"145","author":"Weibull","year":"2019","journal-title":"Int J Cancer"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:24:17Z","timestamp":1793237057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26004795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2772963X26004795"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103058","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality in Patients With Hodgkin Lymphoma and Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103058"}}